Aldomet 250
Aldomet 250 is a medicine authorised by Swissmedic under authorisation number 28080. The authorisation holder is Future Health Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 August 1962 and the authorisation is valid without a time limit. ATC code C02AB01 places the medicine in the group Antihypertensives.
| Authorisation number | 28080 |
|---|---|
| Name | Aldomet 250 |
| Full name | Aldomet 250, Filmtabletten |
| Authorisation holder | Future Health Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C02AB01 |
| First authorisation | 17 August 1962 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Aldomet 250, Filmtabletten | B | 17 August 1962 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 26 | 100 | Tablette(n) | C02AB01 | 02.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Aldomet 250 authorised in Switzerland?
Yes. Aldomet 250 is authorised by Swissmedic under authorisation number 28080, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Aldomet 250 have?
Aldomet 250 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Aldomet 250?
The authorisation holder is Future Health Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.